Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

Updates in Combination Therapy for HCC

Yale Cancer Center

S. Stein

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

SIR 2023: Histotripsy - Technology and Clinical Evidence

SIR 2023 Conference Coverage

T. Ziemlewicz

Hepatic Hilar Nerve Block for Adjunctive Analgesia during Percutaneo…

Dennis Parhar

Evolving Options for the Treatment of HCC With IO and Liver-Directed…

The France Foundation

A. Smolock, B. George

Hepatic Arterial Infusion for Primary Liver Cancer

Integrity CE

K. Lafaro

HCC Percutaneous Radio-Ablation Using BAT-90: Results of an Ongoing …

Malkhaz Mizandari

SIR 2024 Insights: Route90 US IDE Pivotal Study Early Results in Rad…

SIR 2024 Insights

A. Kennedy

Expert Panel on Sequencing Treatments in HCC

Integrity CE

M. Pishvaian, R. Finn, A. Singal, R. Salem

How to Incorporate Molecular Testing in Therapy for Localized Cholan…

Flavio Rocha

Evolving Surgical Strategies in HCC

Yale Cancer Center

K. Billingsley

Expert Panel on Choosing Systemic vs. Locoregional Therapy in HCC

Integrity CE

M. Pishvaian, A. Singal, R. Finn, R. Salem

Expert Panel on TACE and TARE for HCC: Weighing the Pros and Cons

Integrity CE

M. Pishvaian, R. Salem

Colorectal Liver Metastases: Liver-Directed Therapies - Embolization…

Penn Medicine Abramson Cancer Center

M. Soulen

New and Evolving Clinical Trials: Embolotherapy

SIR 2022 Coverage

M. Soulen

Updates in Radiation Therapy for GI Cancers

Total Health

N. Sanford

Approach to the Patient with a Liver Mass

Cedars Sinai

W. Ayoub

Old and New: Treatment Updates for Early-Stage Hepatocellular Carcin…

Keck School of Medicine of USC

K. Zhou